M. Casal

发表

Rapid, simple, and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis.

K. Feldmann, S. Rüsch-Gerdes, C. Truffot-Pernot, 2000, The American journal of tropical medicine and hygiene.

Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples.

K. Feldmann, S. Rüsch-Gerdes, V. Jarlier, 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

GenoType Mycobacterium Assay for Identification of Mycobacterial Species Isolated from Human Clinical Samples by Using Liquid Medium

M. Casal, J. Gutierrez, P. Ruiz, 2002, Journal of Clinical Microbiology.

Comparison of Two Molecular Methods for Rapid Diagnosis of Extrapulmonary Tuberculosis

M. Casal, P. Ruiz, M. Causse, 2011, Journal of Clinical Microbiology.

Multicenter study of incidence of Mycobacterium marinum in humans in Spain.

M. Casal, M. Casal, M. Casal, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosis.

M. Casal, P. Ruiz, F. J. Zerolo, 2002, Microbial drug resistance.

Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis.

M. Casal, J. Gutierrez, P. Ruiz, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Promising new drugs in the treatment of tuberculosis and mycobacteriosis.

G. Moreno, R. Villalba, M. Casal, 1989, Journal of chemotherapy.

Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis

M. Vaquero, M. Casal, J. Gutierrez, 2017, Infection and drug resistance.

Age-Dependent Association between Low Frequency of CD27/CD28 Expression on pp65 CD8 (cid:1) T Cells and Cytomegalovirus Replication after Transplantation (cid:1)

R. Solana, A. Rodríguez-Benot, J. Torre-Cisneros, 2009 .

Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach.

K. Feldmann, E. Richter, E. Tortoli, 2001, Molecular and cellular probes.

In vitro activity of roxithromycin against the Mycobacterium tuberculosis complex

Nalin Rastogi, K. S. Goh, M. Casal, 1995, Antimicrobial agents and chemotherapy.

Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance.

M. Casal, P. Ruiz, A. Herreras, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Evaluation of the COBAS TaqMan 48 Real-Time PCR System for Quantitation of Hepatitis B Virus DNA

M. Casal, J. Gutierrez, R. M. Gordillo, 2005, Journal of Clinical Microbiology.

In vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic: RU-28965.

M. Casal, J. Gutierrez, P. Ruiz, 1987, Tubercle.

[Antimicrobial resistance in tuberculosis].

M. Casal, P. Ruiz, J. Gutiérrez-Aroca, 2013, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Evaluation of the GenoType Mycobacteria Direct Assay for Detection of Mycobacterium tuberculosis Complex and Four Atypical Mycobacterial Species in Clinical Samples

M. Casal, J. Gutierrez, F. Franco-Álvarez de Luna, 2006, Journal of Clinical Microbiology.

In Vitro Activity of Tedizolid against Mycobacterium tuberculosis

M. Vaquero, M. Casal, P. Ruiz, 2019, Antimicrobial Agents and Chemotherapy.

Surveillance of Drug-Resistant Tuberculosis in Spain (2001-2015).

M. Vaquero, M. Casal, P. Ruiz, 2018, Microbial Drug Resistance.

[Clinical interest of a new simple system for isolating Mycobacterium tuberculosis].

M. Vaquero, M. Casal, J. Gutierrez, 1997, Revista clínica española (Ed. impresa).

Activity of rifampin against Mycobacterium tuberculosis in a reference center.

M. Casal, J. Gutierrez, P. Ruiz, 2004, Microbial drug resistance.

Current interest of isoniazid in the chemotherapy of tuberculosis in the light of its in vitro activity.

M. Casal, P. Ruiz, F. J. Zerolo, 2003, Microbial drug resistance.

In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.

M. Casal, J. Gutierrez, P. Ruiz, 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[Streptomycin as second-line chemotherapy for tuberculosis].

M. Casal, P. Ruiz, F. J. Zerolo, 2003, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries.

S. Rüsch-Gerdes, V. Jarlier, J. Grosset, 2005, Microbial drug resistance.